Sun Pharma Gets FDA Warning After Inspection of FacilityBy
FDA withholds future approvals from company's Halol Facility
Company working on completing its remediation process
Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, has received a warning letter from the U.S. Food and Drug Administration following an inspection at one of its facilities.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.